BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26978609)

  • 1. [Results of circulatory disease detection during prophylactic medical examination of the adult population: the first two years' experience].
    Kalinina AM; Ipatov PV; Kushunina DV; Egorov VA; Drozdova LY; Boytsov SA
    Ter Arkh; 2016; 88(1):46-52. PubMed ID: 26978609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of malignancy detection during prophylactic medical examinations in 2013-2014].
    Aleksandrova LM; Starinsky VV; Kalinina AM; Kaprin AD; Boytsov SA
    Ter Arkh; 2016; 88(1):60-66. PubMed ID: 26978611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of circulatory diseases and their risk during medical examination of an adult population: methodological aspects].
    Kalinina AM; Ipatov PV; Kaminskaya AK; Kushunina DV
    Ter Arkh; 2015; 87(1):31-37. PubMed ID: 25823267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases.
    Puska P; Vartiainen E; Tuomilehto J; Salomaa V; Nissinen A
    Bull World Health Organ; 1998; 76(4):419-25. PubMed ID: 9803593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of quality of implementation of preventive medical examinations of underage persons in the Russian Federation].
    Baranov AA; Namazova-Baranova LS; Terletskaia RN; Baibarina EN; Chumakova OV; Ustinova NV; Antonova EV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2017; 25(1):23-9. PubMed ID: 29558599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New clinical and organizational approaches to preventing cardiovascular diseases in the primary health care system].
    Boĭtsov SA; Kalinina AM; Ipatov PV
    Ter Arkh; 2013; 85(8):8-13. PubMed ID: 24137958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of risk factors and early manifestations of cardiovascular diseases during ambulatory examination of working age persons].
    Dokina ED; Dorofeeva EV; Dubrovina EV; Alekseeva LA; Sidorenko BA
    Kardiologiia; 2011; 51(10):75-80. PubMed ID: 22117685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent trends in and new data on the epidemiology and prevention of non-communicable diseases].
    Boytsov SA
    Ter Arkh; 2016; 88(1):4-10. PubMed ID: 26978602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis in Iceland. 1976].
    Sigurdsson S
    Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial infarction morbidity and mortality in the Russian Federation in 2000-2011].
    Oshchepkova EV; Efremova IuE; Karpov IuA
    Ter Arkh; 2013; 85(4):4-10. PubMed ID: 23808284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey.
    Valero-Elizondo J; Salami JA; Ogunmoroti O; Osondu CU; Aneni EC; Malik R; Spatz ES; Rana JS; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):143-53. PubMed ID: 26941417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of cardiovascular prevention in primary care: implications of a European observational study in 8928 patients at different risk levels.
    Ludt S; Wensing M; Campbell SM; Ose D; van Lieshout J; Rochon J; Uhlmann L; Szecsenyi J
    Eur J Prev Cardiol; 2014 Feb; 21(2):203-13. PubMed ID: 23000862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a systematic cardiovascular disease risk reduction strategy in primary healthcare: an exploratory study from Zhejiang, China.
    Zou G; Wei X; Gong W; Yin J; Walley J; Yu Y; Zhang Z; King R; Hu R; Chen K; Yu M
    J Public Health (Oxf); 2015 Jun; 37(2):241-50. PubMed ID: 24696086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ASSESSING THE RELIABILITY OF A PULMONARY TUBERCULOSIS MORBIDITY RATE].
    Tuberk Biolezni Legkih; 2010; (4):3-9. PubMed ID: 27534018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular Diseases in the Context of Russia's Long-Term Socio-Economic Development Priorities].
    Saygitov RT; Chulok AA
    Vestn Ross Akad Med Nauk; 2015; (3):286-99. PubMed ID: 26495716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rank-order method for the integrated assessment of trends in all-cause and cardiovascular mortality rates in the subjects of the Russian Federation in 2006-2012].
    Artamonova GV; Maksimov SA; Tabakaev MV; Barbarash LS
    Ter Arkh; 2016; 88(1):11-16. PubMed ID: 26978603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported cerebrovascular and heart diseases and cardiovascular risk factors in Portugal: the AMALIA study.
    Macedo A; Santos A; Rocha E; Perdigão C
    Rev Port Cardiol; 2008 May; 27(5):569-80. PubMed ID: 18717211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic cardiovascular disease screening in adults: American College Of Preventive Medicine position statement on preventive practice.
    Lim LS; Haq N; Mahmood S; Hoeksema L; ;
    Am J Prev Med; 2011 Mar; 40(3):381.e1-10. PubMed ID: 21335273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.